SYMLIN Market OpportunityNorth America and Western Europe
Over 32 million people with diabetes in
North America and Western Europe
Source: Amylin internal data
SYMLIN
Target
Population
UsingInsulin
8.2 M
Not Using Insulin
13.4 M
Not Diagnosed
10.5 M
Previous slide
Next slide
Back to first slide
View graphic version